Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Cang-Bao Xu"'
Publikováno v:
Microvascular research. 139
To explore whether minimally modified low-density lipoprotein (mmLDL) upregulates mesenteric arterial 5-hydroxytryptamine 1B (5-HTMice were randomly divided into the following groups: the normal saline (NS), LDL, mmLDL, mmLDL+galiellactone (GL, a JAK
Autor:
Kun Li, Andong Zhao, Li Xu, Yunting Zhang, Ying Chen, Cang-Bao Xu, Wei Mengqian, Chuan Wang, Zhenhao Huang, Yu Qi, Zhang Yaping, Lian Ting, Fuqiang Liu
Publikováno v:
Toxicology and Applied Pharmacology. 414:115420
As a VEGF-targeting agent, sorafenib has been used to treat a number of solid tumors but can easily lead to adverse vascular effects. To elucidate the underlying mechanism, rat mesenteric arteries were subjected to organ cultured in the presence of d
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 120:327-334
Abnormal contraction of vessels termed 'vasospasm' is associated with various cardiovascular diseases. Smoking is a well-known risk factor that increases vasospasm. However, the molecular mechanisms by which smoking leads to vasospasm and cardiovascu
Publikováno v:
Advances in Pharmacological Sciences, Vol 2017 (2017)
Zhang, Y, Mi, M, Xie, Y-H, Wang, S-W, Edvinsson, L & Xu, C-B 2017, ' Downregulation of Thromboxane A 2 Receptor Occurs Mainly via Nuclear Factor-KappaB Signaling Pathway in Rat Renal Artery ', Advances in Pharmacological Sciences, vol. 2017, 6507048 . https://doi.org/10.1155/2017/6507048
Zhang, Y, Mi, M, Xie, Y-H, Wang, S-W, Edvinsson, L & Xu, C-B 2017, ' Downregulation of Thromboxane A 2 Receptor Occurs Mainly via Nuclear Factor-KappaB Signaling Pathway in Rat Renal Artery ', Advances in Pharmacological Sciences, vol. 2017, 6507048 . https://doi.org/10.1155/2017/6507048
Thromboxane A2 (TXA2) acts on TXA2 receptors (TP) to regulate renal artery blood flow and subsequently contributes to the pathogenesis of renal ischemia. The present study was designed to examine if nuclear factor-kappaB (NF-κB) signaling pathway is
Autor:
Xi Xu, Jing Tan, Nan Li, Cang-Bao Xu, Qindong Shi, Junfeng Zhang, Lingyu Zhao, Sheng-feng Ji, Jianshui Zhang, Pengbo Yang, Zhao-hua Zhao
Publikováno v:
Cancer Cell International, Vol 18, Iss 1, Pp 1-13 (2018)
Cancer Cell International
Cancer Cell International
Background MicroRNAs play crucial roles in tumorigenesis and tumor progression. miR-770 has been reported to be downregulated in several cancers and affects cancer cell proliferation, apoptosis, metastasis and drug resistance. However, the role and u
Autor:
Yaping Zhang, Cang-Bao Xu
Publikováno v:
Pathology - Research and Practice. 216:153083
Chronic exposure to cigarette smoke is the major risk factor for the development of pulmonary hypertension (PH) with chronic lung disease (i.e. PH group III). The pathogenesis of smoke-associated PH group III in chronic obstructive pulmonary disease
Publikováno v:
Vascular pharmacology.
Minimally modified low density lipoprotein (mmLDL) is a risk factor for cardiovascular disease. This study investigated the effect of mmLDL on mouse mesenteric artery endothelin type B (ET
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 84
Hyperhomocysteinemia is an independent risk factor for cardiovascular diseases (CVDs). Endothelin type B (ETB) receptors were involved in the pathogenesis of CVDs. However, Sirtuin 1(Sirt1) has potential protect roles for CVDs. The present study was
Publikováno v:
Mediators of Inflammation, Vol 2013 (2013)
Mediators of Inflammation
Mediators of Inflammation
Minimally modified low-density lipoprotein (mmLDL) is a risk factor for cardiovascular disease. The present study investigated the effects of mmLDL on the expression of endothelin type A () receptors in coronary arteries. Rat coronary arteries were o
Publikováno v:
Vascular pharmacology. 87
Vascular smooth muscle endothelin type B (ETB) receptor is involved in the pathogenesis of cardiovascular diseases (CVDs). Hyperhomocysteinemia is an independent risk factor for CVDs. The present study was designed to examine the hypothesis that homo